A retrospective cohort analysis comparing pregnancy rates among HIV-positive women using contraceptives and efavirenz- or nevirapine-based antiretroviral therapy in Kenya

PATEL, Rena C.; ONONO, Maricianah; GANDHI, Monica; BLAT, Cinthia; HAGEY, Jill; SHADE, Starley B.; VITTINGHOFF, Eric; BUKUSI, Elizabeth A.; NEWMANN, Sara J.; COHEN, Craig R.

doi:10.1016/S2352-3018(15)00184-8

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

A retrospective cohort analysis comparing pregnancy rates among HIV-positive women using contraceptives and efavirenz- or nevirapine-based antiretroviral therapy in Kenya

Published Date:

Oct 22 2015

Publisher's site:

http://dx.doi.org/10.1016/S2352-3018(15)00184-8 New Site Icon

Source:

Lancet HIV. 2(11):e474-e482.

[PDF-230.45 KB]

Details:

Personal Authors:

PATEL, Rena C. ; ONONO, Maricianah ; GANDHI, Monica ; BLAT, Cinthia ; HAGEY, Jill ; ... More ▼

Keywords:

[+]

Pubmed ID:

26520927

Pubmed Central ID:

PMC4632202

Description:

Background

Given recent concerns of efavirenz reducing the efficacy of contraceptive implants, we sought to determine if pregnancy rates differ among HIV-positive women using various contraceptive methods and efavirenz- or nevirapine-based antiretroviral therapy (ART) regimens.

Methods

We conducted a retrospective cohort analysis of HIV-positive women aged 15–45 years enrolled in HIV care facilities in western Kenya from January 2011 to December 2013. Pregnancy was diagnosed clinically and the primary exposure was a combination of contraceptive method and ART regimen. We used Poisson models, adjusting for repeated measures, as well as demographic, behavioral and clinical factors, to compare pregnancy rates among women on different contraceptive/ART combinations.

Findings

24,560 women contributed 37,635 years of follow-up with 3,337 incident pregnancies. Among women using implants, adjusted pregnancy incidence for nevirapine- and efavirenz-based ART users were 1·1 (95% CI 0·72–1·5) and 3·3 (95% CI 1·8–4·8) per 100 women-years (w-y), respectively (adjusted incidence rate ratio (aIRR) 3·0, 95% CI 1·3–4·6). Among women using depomedroxyprogesterone acetate (DMPA), adjusted pregnancy incidence for nevirapine- and efavirenz-based ART users were 4·5 (95% CI 3·7–5·2) and 5·4 (95% CI 4·0–6·8) per 100 w-y, respectively (aIRR 1·2, 95% CI 0·91–1·5). Women using other contraceptive methods, except for intrauterine devices and permanent methods, experienced 3·1–4·1 higher rates of pregnancy than women using implants, with 1·6–2·8 higher rates specifically among women using efavirenz-based ART.

Interpretation

While HIV-positive women using implants on efavirenz-based ART faced three times higher risk of contraceptive failure than those on nevirapine-based ART, these women still experienced lower contraceptive failure rates than women on all other contraceptive methods, except for intrauterine devices and permanent methods. Guidelines for contraceptive and ART combinations should balance the failure rates for each contraceptive method and ART regimen combination against the high effectiveness of implants.

Funding

Supported by the President’s Emergency Plan for AIDS Relief and the Centers for Disease Control and Prevention.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

KL2 TR000143/TR/NCATS NIH HHS/United States
T32AI007641/AI/NIAID NIH HHS/United States
T32 AI007641/AI/NIAID NIH HHS/United States
KL2TR000143/TR/NCATS NIH HHS/United States
PS001913/PS/NCHHSTP CDC HHS/United States
R01 AI098472/AI/NIAID NIH HHS/United States
K23 AI120855/AI/NIAID NIH HHS/United States
PEPFAR/United States
K23AI120855/AI/NIAID NIH HHS/United States

Supporting Files:

	NIHMS732884-supplement-1.pdf	application/pdf
	nihms732884.nxml	application/octet-stream

No Related Documents.

You May Also Like:

Effectiveness of Hormonal Contraception in HIV-Infected Women using Antiretroviral Therapy: A Prospective Study

Personal Author:

Pyra, Maria; Heffron, Renee; Mugo, Nelly R.; Nanda, Kavita; Thomas, Katherine K.; Celum, Connie; Kourtis, Athena P.; Were, Edwin; Rees, Helen; Bukusi, Elizabeth; Baeten, Jared M.;

Corporate Author:

for the Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams

Published:

Nov 2015

Source:

AIDS. 29(17):2353-2359.

Description:

Objective : To assess whether antiretroviral therapy (ART) may diminish the effectiveness of hormonal contraceptive methods. : Methods : Using data from 5,153 HIV-infected women followed prospectively one to three years in three HIV prevention studie...

File Type:

[PDF - 147.19 KB]
Efavirenz Conceptions and Regimen Management in a Prospective Cohort of Women on Antiretroviral Therapy

Personal Author:

Schwartz, Sheree; Taha, Taha E.; Venter, Willem Daniel Francois; Mehta, Shruti; Rees, Helen; Black, Vivian;

Published:

Jun 15 2012

Source:

Infect Dis Obstet Gynecol. 2012; 2012.

Description:

Use of the antiretroviral drug efavirenz (EFV) is not recommended by the WHO or South African HIV treatment guidelines during the first trimester of pregnancy due to potential fetal teratogenicity; there is little evidence of how clinicians manage EF...

File Type:

[PDF - 670.89 KB]
Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.

Published:

September 14, 2011

Status:

current

File Type:

[PDF - 155.10 MB]
Research and evaluation agenda for HIV and maternal health in sub-Saharan Africa

Personal Author:

Kendall, Tamil; Danel, Isabella;

Corporate Author:

Harvard School of Public Health. Maternal Health Task Force.; Centers for Disease Control and Prevention (U.S.); National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Reproductive Health.; United States. Agency for International Development.;

Published:

January 2014

Series:

Women and Health Initiative working paper ; no. 1

Description:

In June 2013, a group of international maternal health and HIV researchers came together in Boston under the auspices of the Maternal Health Task Force (MHTF) at the Harvard School of Public Health, the United States Agency for International Developm...

File Type:

[PDF - 3.52 MB]
Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus; principles of therapy and revised recommendations

Personal Author:

Villarino, M. Elsa

Corporate Author:

Centers for Disease Control and Prevention (U.S.); National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.;

Conference Author:

CDC Conference on HIV-Related Tuberculosis (1997 : Atlanta, Georgia)

Published:

October 30, 1998

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 47, no. 20

Description:

"These guidelines update previous CDC recommendations for the diagnosis, treatment, and prevention of tuberculosis (TB) among adults and children coinfected with human immunodeficiency virus (HIV) in the United States. The most notable changes in the...

Status:

superseded

File Type:

[PDF - 743.08 KB]